World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
131
Citations
64608
World Ranking
339
National Ranking
207

Medicine

D-Index
137
Citations
70613
World Ranking
1908
National Ranking
1083

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Marina Konopleva is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a significant concentration in Hematology, Molecular Biology, Genetics, Public Health, Environmental and Occupational Health, and Oncology.

The scientist's work encompasses a variety of topics, notably in leukemia research and treatment. These include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • CAR-T Cell Therapy Research
  • Histone Deacetylase Inhibitors Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Marina Konopleva has contributed to several recent publications, such as:

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia, 2020, New England Journal of Medicine
  • Acute myeloid leukemia: current progress and future directions, 2021, Blood Cancer Journal
  • 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party, 2021, Blood
  • Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML, 2020, Blood
  • Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges, 2020, Cancer Discovery

The most frequent co-authors associated with their work are:

  • Hagop M. Kantarjian
  • Farhad Ravandi
  • Courtney D. DiNardo
  • Elias Jabbour
  • Tapan M. Kadia

Marina Konopleva has published extensively in several key medical journals, including:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • American Journal of Hematology
  • Blood Advances
  • Journal of Clinical Oncology

Best Publications

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

    Courtney D DiNardo;Brian A Jonas;Vinod Pullarkat;Michael J Thirman

  • Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.

    Courtney D. DiNardo;Keith Pratz;Vinod Pullarkat;Brian A. Jonas

  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey

  • Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

    Marina Konopleva;Rooha Contractor;Twee Tsao;Ismael Samudio

  • Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

    Marina Konopleva;Daniel A. Pollyea;Jalaja Potluri;Brenda Chyla

  • An inhibitor of oxidative phosphorylation exploits cancer vulnerability.

    Jennifer R. Molina;Yuting Sun;Marina Protopopova;Sonal Gera

  • Antidiabetic therapies affect risk of pancreatic cancer

    Donghui Li;Sai–Ching J. Yeung;Manal M. Hassan;Marina Konopleva

  • Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.

    Courtney D DiNardo;Keith W Pratz;Anthony Letai;Brian A Jonas

  • Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

    Ismael Samudio;Romain Harmancey;Michael Fiegl;Hagop Kantarjian

  • Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

    Rongqing Pan;Leah J. Hogdal;Juliana M. Benito;Donna Bucci

  • Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML

    Zhihong Zeng;Yue Xi Shi;Ismael J. Samudio;Rui Yu Wang

  • Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.

    C. D. DiNardo;I. S. Tiong;I. S. Tiong;A. Quaglieri;S. MacRaild

  • Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.

    M Konopleva;S Konoplev;W Hu;AY Zaritskey

  • Acute myeloid leukemia: current progress and future directions.

    Hagop Kantarjian;Tapan Kadia;Courtney DiNardo;Naval Daver

  • Ibrutinib and venetoclax for first-line treatment of CLL

    Nitin Jain;Michael Keating;Philip Thompson;Alessandra Ferrajoli

  • Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

    Alfonso Quintás-Cardama;Hagop Kantarjian;Taghi Manshouri;Rajyalakshmi Luthra

  • 2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document.

    Michael Heuser;Sylvie D Freeman;Gert J Ossenkoppele;Francesco Buccisano

  • MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.

    Kensuke Kojima;Marina Konopleva;Marina Konopleva;Ismael J. Samudio;Ismael J. Samudio;Masato Shikami;Masato Shikami

  • PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia

    Zhaohui Gu;Michelle L. Churchman;Kathryn G. Roberts;Ian Moore

  • Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia

    Farhad Ravandi;Jorge E Cortes;Daniel Jones;Stefan H Faderl

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Michael Andreeff
Michael Andreeff The University of Texas MD Anderson Cancer Center
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Elias Jabbour
Elias Jabbour The University of Texas MD Anderson Cancer Center
Naval Daver
Naval Daver The University of Texas MD Anderson Cancer Center
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Nitin Jain
Nitin Jain The University of Texas MD Anderson Cancer Center
Sherry Pierce
Sherry Pierce The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a medical career but want flexibility or are looking for alternative entry points, there are many online degree options in healthcare. Online nursing courses are popular for those who wish to obtain foundational skills or specialize in areas such as pediatrics, gerontology, or public health. These programs are especially suitable for balancing study with work or family commitments.

For practicing nurses aiming to advance their qualifications, the rn to bsn online cost is a key consideration, as affordability plays a vital role in choosing the right program. Higher-level roles and academic opportunities often require advanced degrees—online nursing phd programs cater to those interested in research or teaching at the collegiate level.

Additionally, direct entry msn programs online provide a pathway for individuals from different educational backgrounds to enter nursing with a master’s qualification in an accelerated timeframe. These diverse online pathways help make healthcare education more accessible for students across the U.S.

Best Scientists Citing Marina Konopleva

Trending Scientists